Graphite Bio
FinanceINDUSTRY newsLife Science
Healthpeak’s $169MM Write-Down in South San Francisco Signals Biotech Real Estate Reality Check
The company that helped launch the Bay Area’s lab building boom now faces the sector’s downturn, but executives see recovery ahead Denver-based Healthpeak...
FinanceINDUSTRY newsLife Science
Alaska Permanent Fund Corp. Invests $141.5MM in 551,000 SQFT South San Francisco Life Science Project
By Kate Snyder In a move that diverges from prevailing market trends, the Alaska Permanent Fund Corporation has announced an investment of $216.5...
AECCommercialINDUSTRY newsLife Science
Healthpeak Announces Full Lease-up of 148,000 SQFT Nexus on Grand Project in South San Francisco
DENVER, Feb. 8, 2022 — Healthpeak Properties, Inc. (NYSE: PEAK) announced today the execution of long-term leases with Graphite Bio, Inc. and another leading biotech...
CommercialINDUSTRY newsNews Releases
Gene Editing Firm, Graphite Bio, Takes +85,000 SQFT Lease at Nexus on Grand in South San Francisco
Next-generation gene editing company to occupy three full floors of ground-up, Class A life sciences development in one of the top biotech markets...
